Ryman Healthcare Limited Stock Market Value
| RHCGF Stock | USD 2.61 0.00 0.00% |
| Symbol | Ryman |
Ryman Healthcare 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ryman Healthcare's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ryman Healthcare.
| 11/14/2024 |
| 12/14/2024 |
If you would invest 0.00 in Ryman Healthcare on November 14, 2024 and sell it all today you would earn a total of 0.00 from holding Ryman Healthcare Limited or generate 0.0% return on investment in Ryman Healthcare over 30 days. Ryman Healthcare is related to or competes with Pennant, Encompass Health, Enhabit, Concord Medical, National HealthCare, Ensign, and InnovAge Holding. Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the ... More
Ryman Healthcare Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ryman Healthcare's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ryman Healthcare Limited upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 19.3 |
Ryman Healthcare Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ryman Healthcare's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ryman Healthcare's standard deviation. In reality, there are many statistical measures that can use Ryman Healthcare historical prices to predict the future Ryman Healthcare's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.09) | |||
| Total Risk Alpha | (0.35) | |||
| Treynor Ratio | 0.65 |
Ryman Healthcare Backtested Returns
Ryman Healthcare maintains Sharpe Ratio (i.e., Efficiency) of -0.0524, which implies the firm had a -0.0524% return per unit of risk over the last 3 months. Ryman Healthcare exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Ryman Healthcare's Risk Adjusted Performance of (0.03), coefficient of variation of (1,923), and Variance of 3.63 to confirm the risk estimate we provide. The company holds a Beta of -0.17, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Ryman Healthcare are expected to decrease at a much lower rate. During the bear market, Ryman Healthcare is likely to outperform the market. At this point, Ryman Healthcare has a negative expected return of -0.1%. Please make sure to check Ryman Healthcare's information ratio, skewness, as well as the relationship between the Skewness and day median price , to decide if Ryman Healthcare performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.00 |
No correlation between past and present
Ryman Healthcare Limited has no correlation between past and present. Overlapping area represents the amount of predictability between Ryman Healthcare time series from 14th of November 2024 to 29th of November 2024 and 29th of November 2024 to 14th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ryman Healthcare price movement. The serial correlation of 0.0 indicates that just 0.0% of current Ryman Healthcare price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | -0.4 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Ryman Healthcare lagged returns against current returns
Autocorrelation, which is Ryman Healthcare pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Ryman Healthcare's pink sheet expected returns. We can calculate the autocorrelation of Ryman Healthcare returns to help us make a trade decision. For example, suppose you find that Ryman Healthcare has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Ryman Healthcare regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Ryman Healthcare pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Ryman Healthcare pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Ryman Healthcare pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Ryman Healthcare Lagged Returns
When evaluating Ryman Healthcare's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Ryman Healthcare pink sheet have on its future price. Ryman Healthcare autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Ryman Healthcare autocorrelation shows the relationship between Ryman Healthcare pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Ryman Healthcare Limited.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Ryman Pink Sheet
Ryman Healthcare financial ratios help investors to determine whether Ryman Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ryman with respect to the benefits of owning Ryman Healthcare security.